Don't know, but don't think so. To me it just looks like someone had around 20,000 shares to sell. There's so little vlolume that the MM took the stock down significantly to pick up those shares on the other side of the trade. Sure, it may drop further to a technical support level below $5, but I would also not be surprised if it rallys back today to near $5.70 Either way, I'm holding for the duration...until their drug is approved or fails.
A big boy gets nervous and gets out with a small bottom fishing gain. This thing trades like a bulletin board stock.I'll bet someone had second thoughts. It has no major brokerage following and looks pretty marginal to the outside observers. It's easy to get scared about ru486 and think they'l never approve corlux. The right to lifers getting influence in the FDA. It would be typical that backlash might wash away an otherwise good psych drug.This may make the pop even better if the early indications of efficacy are allowed to be explored clinically.-No Other gr2 receptor antagonist on the market and broad biologic effects on the cns cortisol receptor and acth cortisol and many other neurotransmitter systems effects yet to be understood but possibly powerful in treating stimulant induced psychosis ie meth,coc,pcp,steroid induced besides unipolar and bipolar related depression and psychosis.